CEO Files Intent to Sell Over $5 Million in Company Stock

summarizeSummary

Protagonist Therapeutics' CEO filed a Form 144 to sell $5.39 million in stock, continuing a pattern of insider sales.

check_boxKey Events

• CEO Files Intent to Sell Shares

  Dinesh Patel, CEO of Protagonist Therapeutics, filed a Form 144 to sell 54,700 shares of common stock.

• Significant Proposed Transaction Value

  The proposed sale is valued at approximately $5.39 million.

• Follows Recent Insider Sales

  This intent to sell follows previous sales by the CEO totaling $4.06 million in the past three months, contributing to a net insider distribution of nearly $13 million over 90 days.

• Part of Ongoing Insider Distribution

  This filing is part of an ongoing pattern of insider sales, with 10 similar filings from various insiders in the last 90 days.

auto_awesomeAnalysis

Protagonist Therapeutics' CEO, Dinesh Patel, has filed a Form 144 indicating an intent to sell 54,700 shares of common stock, valued at approximately $5.39 million. This proposed sale follows previous sales by the CEO totaling over $4 million in the past three months, contributing to a broader pattern of insider distribution. While the percentage of market cap is small, the absolute dollar value and the CEO's role make this a notable event, signaling a continued reduction in executive holdings.